MedPath

SK Plasma Co., Ltd.

SK Plasma Co., Ltd. logo
🇰🇷South Korea
Ownership
Subsidiary
Established
2015-03-05
Employees
11
Market Cap
-
Website
http://www.skplasma.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:1
Phase 3:3

Drug Approvals

2

NMPA:2

Drug Approvals

Human Albumin

Product Name
人血白蛋白
Approval Number
国药准字SJ20150046
Approval Date
Apr 12, 2021
NMPA

Human Albumin

Product Name
人血白蛋白
Approval Number
S20150047
Approval Date
Sep 22, 2015
NMPA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (75.0%)
Phase 2
1 (25.0%)

An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients

Phase 3
Not yet recruiting
Conditions
Hemophilia A, Severe
Interventions
First Posted Date
2024-12-18
Last Posted Date
2024-12-18
Lead Sponsor
SK Plasma Co., Ltd.
Target Recruit Count
55
Registration Number
NCT06738901

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation

Phase 2
Terminated
Conditions
Liver Transplantation
First Posted Date
2022-12-27
Last Posted Date
2024-08-30
Lead Sponsor
SK Plasma Co., Ltd.
Target Recruit Count
59
Registration Number
NCT05666453

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Phase 3
Completed
Conditions
Immune Thrombocytopenia
First Posted Date
2022-10-05
Last Posted Date
2022-10-05
Lead Sponsor
SK Plasma Co., Ltd.
Target Recruit Count
34
Registration Number
NCT05566990
Locations
🇰🇷

Dong-A University Hospital, Busan, Korea, Republic of

🇰🇷

Kosin University Gospel Hospital, Busan, Korea, Republic of

🇰🇷

Pusan National University Hospital, Busan, Korea, Republic of

and more 8 locations

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Phase 3
Completed
Conditions
Immune Thrombocytopenia
First Posted Date
2017-05-24
Last Posted Date
2021-03-30
Lead Sponsor
SK Plasma Co., Ltd.
Target Recruit Count
37
Registration Number
NCT03164915
Locations
🇰🇷

Busan National University Hospital, Busan, Korea, Republic of

🇰🇷

Bundang Seoul National University Hospital, Seongnam, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

and more 3 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath